New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
07:39 EDTCLDXCelldex CDX-1127 data positive, says Oppenheimer
After analyzing ASCO abstracts, Oppenheimer thinks the data indicated that Celldex's CDX-1127 is well-tolerated and capable of inducing an immune response. The firm keeps an Outperform rating on the stock.
News For CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
16:03 EDTCLDXCelldex completes enrollment in Phase 3 ACT IV study
Subscribe for More Information
December 5, 2014
08:44 EDTCLDXCelldex study should increase visibility, partner potential, says Roth Capital
Subscribe for More Information
December 4, 2014
16:09 EDTCLDXCelldex initiates Phase 2 study of Glembatumumab Vedotin
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use